Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance β-cell insulin secretion and viability in min6 cells via PKA-dependent pathways

Bioscience, Biotechnology and Biochemistry

Volumn 72, Issue 11, 2008, Pages 2815-2823

  Park, Sunmin ^a   Ahn, Il Sung ^a   Kwon, Dae Young ^b   Ko, Byoung Seob ^c   Jun, Won Kyung ^c  

^a Hoseo University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

3T3 L1 adipocytes; Ginsenosides; Insulin secretion; Min6 cells; PKA

Indexed keywords

AMINES; BODY FLUIDS; CELLS; CHEMICAL ACTIVATION; FETAL MONITORING; GLUCOSE; HORMONES; INSULIN; PHYSIOLOGY; SUGAR (SUCROSE);

3T3-L1 ADIPOCYTES; GINSENOSIDES; INSULIN SECRETION; MIN6 CELLS; PKA;

CYTOLOGY;

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RG 1; GLUCOSE; INSULIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GINSENOSIDES; GLUCOSE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-SECRETING CELLS; MICE; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

PANAX GINSENG;

EID: 56749161352     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80205     Document Type: Article

References (34)

1. Kahn, S. E., The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46, 3-19 (2003).
2. Rendell, M., The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs, 64, 1339-1358 (2004).
3. Lu, M., and Shyy, J. Y., Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am. J. Physiol. Cell Physiol., 290, C1477-C1486 (2006).
4. Yin, W., Mu, J., and Birnbaum, M. J., Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. J. Biol. Chem., 278, 43074-43080 (2003).
5. Choi, S. B., Jang, J. S., and Park, S., Estrogen and exercise may enhance b-cell function and mass via IRS2 induction in ovariectomized diabetic rats. Endocrinology, 146, 4786-4794 (2005).
6. Park, S., Dong, X., Fisher, T. L., Dunn, S. L., Omer, A. K., Weir, G., and White, M. F., Exendin-4 promotes IRS2 signaling to mediate pancreatic beta-cell growth and function. J. Biol. Chem., 281, 1159-1168 (2006).
7. Kieffer, T. J., and Habener, J. F., The glucagon-like peptides. Endocr. Rev., 20, 876-913 (1999).
8. Habener, J. F., and Kemp, D. M., Insulinotropic glucagon-like peptides. In "Diabetes Mellitus: A Fundamental and Clinical Text," eds. LeRoith, D., Taylon, S. I., and Olefsky, J. M., Lippincott Williams and Wilkins, Philadelphia, pp. 123-134 (2004).
9. Ding, X., Saxena, N. K., Lin, S., Gupta, N. A., and Anania, F. A., Exendin-4, a glucagon-like protein-1 receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology, 43, 173-181 (2006).
10. Attele, A. S., Zhou, Y. P., Xie, J. T., Wu, J. A., Zhang, L., Dey, L., Pugh, W., Rue, P. A., Polonsky, K. S., and Yuan, C. S., Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 51, 1851-1858 (2002).
11. Kimura, M., Waki, I., Chujo, T., Kikuchi, T., Hiyama, C., Yamazaki, K., and Tanaka, O., Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J. Pharmacobiodyn., 4, 410-417 (1981).
12. Sotaniemi, E. A., Haapakoski, E., and Rautio, A., Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care, 18, 1373-1375 (1995).
13. Vuksan, V., Sievenpiper, J. L., Koo, V. Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z., and Vidgen, E., American Ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch. Intern. Med., 160, 1009-1013 (2000).
14. Attele, A. S., Wu, J. A., and Yuan, C. S., Multiple pharmacological effects of ginseng. Biochem. Pharmacol., 58, 1685-1693 (1999).
15. Park, K. H., Shin, H. J., Song, Y. B., Hyun, H. C., Cho, H. J., Ham, H. S., Yoo, Y. B., Ko, Y. C., Jun, W. T., and Park, H. J., Possible role of ginsenoside Rb1 on regulation of rat liver triglycerides. Biol. Pharm. Bull., 25, 457-460 (2002).
16. Hwang, J. T., Kim, S. H., Lee, M. S., Kim, S. H., Yang, H. J., Kim, M. J., Kim, H. S., Ha, J., Kim, M. S., and Kwon, D. Y., Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem. Biophys. Res. Commun., 364, 1002-1008 (2007).
17. Choi, S. B., Ko, B. S., Park, S. K., Jang, J. S., and Park, S., Insulin sensitizing and α-glycoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma. Life Sci., 78, 934-942 (2006).
18. Zhang, Z., Li, X., Lv, W., Yang, Y., Gao, H., Yang, J., Shen, Y., and Ning, G., Ginsenoside Re reduces insulin resistance through inhibition of JNK and NF-kB. Mol. Endocrinol., 22, 186-195 (2008).
19. Lee, W. K., Kao, S. T., Liu, I. M., and Cheng, J. T., Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Horm. Metab. Res., 39, 347-354 (2007).
20. Lee, W. K., Kao, S. T., Liu, I. M., and Cheng, J. T., Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin. Exp. Pharmacol. Physiol., 33, 27-32 (2006).
21. Shang, W., Yang, Y., Jiang, B., Jin, H., Zhou, L., Liu, S., and Chen, M., Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression. Life Sci., 80, 618-625 (2007).
22. Reusch, J. E., Colton, L. A., and Klemm, D. J., CREB activation induces adipogenesis in 3T3-L1 cells. Mol. Cell. Biol., 20, 1008-1020 (2000).
23. Zhang, J. W., Klemm, D. J., Vinson, C., and Lane, M. D., Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein β gene during adipogenesis. J. Biol. Chem., 279, 4471-4478 (2004).
24. Londos, C., Brasaemle, D. L., Schultz, C. J., Adler-Wailes, D. C., Levin, D. M., Kimmel, A. R., and Rondinone, C. M., On the control of lipolysis in adipocytes. Ann. NY Acad. Sci., 892, 155-168 (1999).
25. Kato, Y., Ozaki, N., Yamada, T., Miura, Y., and Oiso, Y., H-89 potentiates adipogenesis in 3T3-L1 cells by activating insulin signaling independently of protein kinase A. Life Sci., 80, 476-483 (2007).
26. Yin, W., Mu, J., and Birnbaum, M. J., Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. J. Biol. Chem., 278, 43074-43080 (2003).
27. Thomson, D. M., Herway, S. T., Fillmore, N., Kim, H., Brown, J. D., Barrow, J. R., and Winder, W. W., AMP-activated protein kinase phosphorylates transcription factors of the CREB family. J. Appl. Physiol., 104, 429-438 (2008).
28. Hansen, P. A., and Corbett, J. A., Incretin hormones and insulin sensitivity. Trends Endocrinol. Metab., 16, 135-136 (2005).
29. Ding, X., Saxena, N. K., Lin, S., Gupta, N. A., and Anania, F. A., Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology, 43, 173-181 (2006).
30. Montrose-Rafizadeh, C., Yang, H., Wang, Y., Roth, J., Montrose, M. H., and Adams, L. G., Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J. Cell. Physiol., 172, 275-283 (1997).
31. Idris, I., Patiag, D., Gray, S., and Donnelly, R., Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1. Biochem. Pharmacol., 63, 993-996 (2002).
32. Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M. F., and Montminy, M., cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev., 17, 1575-1580 (2003).
33. Matschinsky, F. M., Pdx1 restores beta cell function in Irs2 knockout mice. Diabetes, 51, S394-S404 (2002).
34. Kushner, J. A., Ye, J., Schubert, M., Burks, D. J., Dow, M. A., Flint, C. L., Dutta, S., Wright, C. V., Montminy, M. R., and White, M. F., Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. J. Clin. Invest., 109, 1193-1201 (2002).